Aurinia Pharmaceuticals

Aurinia Pharmaceuticals

Aurinia Pharmaceuticals

Our mission is to develop and deliver treatments to people suffering from debilitating diseases.
Raised
$253.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$173,100,000
Post-IPO equity - 2017
$28,750,000
Post-IPO equity - 2016
Team Size
1–10
Employees
Location
Headquarters
$173,100,000 Post-IPO equity
Twitter

Business Wire-Health on Twitter